The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.50
Bid: 180.00
Ask: 195.00
Change: -5.00 (-2.60%)
Spread: 15.00 (8.333%)
Open: 192.50
High: 192.50
Low: 187.50
Prev. Close: 192.50
TND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Total Voting Rights

19 May 2022 07:00

RNS Number : 0209M
Tandem Group PLC
19 May 2022
 

19 May 2022

 

 Tandem Group plc

(the "Company" or "Group")

 

Appointment of Chief Executive Officer

 

Tandem Group plc (AIM: TND), designers, developers and distributors of sports, leisure and mobility equipment, is delighted to announce the appointment of Peter Kimberley as Chief Executive Officer of the Company with immediate effect.

Peter Kimberley was appointed as a non-executive director of the Company in November 2021 and has more than 30 years retail experience across a number of sectors including the cycle retail sector with specific experience in e-mobility across omnichannel, B2B and B2C offerings - most recently as Chief Executive Officer of Pure Electric Limited, a specialised omnichannel retailer of e-bikes and e-scooters in the UK and Europe.

Peter was previously Managing Director of Cycle Republic (omnichannel), Tredz (online proposition) and Boardman Bikes (brand and design) within Halfords Group PLC between 2013 and 2020. 

Steve Grant, Chairman, commented "We are very pleased that Peter has decided to become CEO. Having been a Non-Executive Director for 6 months, he already has a strong understanding of the business and will be able to add real value, utilising his wide and varied experience in senior leadership roles will serve to drive the Group's strategic direction and maximise shareholder value."

To facilitate an orderly transition of executive duties, Steve Grant will remain Executive Chairman until the conclusion of the Company's annual general meeting to be held on 23 June 2022, at which point he will resume his role of Non-Executive Chairman.

 

In connection with his appointment, Mr. Kimberley has today been awarded 37,500 options to subscribe for ordinary shares in the Company under the Company's 2019 Employee Share Option Scheme (the "Options"). Any future exercises of Options will be satisfied from existing ordinary shares held in treasury by the Company.

 

The Options are exercisable from 31 December 2024 at a price of 325 pence per ordinary share.

 

In addition, Mr Kimberley has been awarded 37,500 ordinary shares in the Company, These ordinary shares cannot be sold within 12 months and thereafter only with agreement from the Board. These shares will be satisfied by the transfer of ordinary shares held by the Company in treasury.

 

Following the above transaction, the Company continues to have a total of 6,013,480 ordinary shares in issue, each carrying the right to one vote. On 3 May 2022 a further 17,000 options to subscribe for ordinary shares were exercised by an employee of the Group under the 2019 Employee Share Option Scheme, which were satisfied from existing ordinary shares held in treasury. As a result, 603,921 ordinary shares are currently held in treasury. The total number of voting rights in the Company is therefore 5,409,559 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Following the issue, Mr Kimberley holds 37,500 ordinary shares representing approximately 0.69% of the Company's issued ordinary share capital.

 

The notification set out below, made in accordance with the requirements of Article 19 of the Market Abuse Regulation, provides further details of such dealings.

 

Enquiries:

 

Tandem Group plc

David Rock, Company Secretary

Telephone 0121 748 8075

 

Nominated Adviser

Cenkos Securities plc (Nominated Adviser and Broker)

Ben Jeynes / Dan Hodkinson - Corporate Finance

Michael Johnson / Russell Kerr - Sales

Telephone 020 7397 8900

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Peter Kimberley

2

Reason for notification

a.

Position/Status

Chief Executive Officer

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Tandem Group plc

b.

LEI

213800WKK3A6NMOB6788

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 25p each

 

ISIN: GB00B460T373

b.

Nature of the transaction

1. Award of options to subscribe for new ordinary shares at 325 pence per ordinary share

2. Award of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. Nil

2. Nil

37,500

37,500

 

d.

Aggregated information

- Aggregated Volume

- Price

N/A - single transactions

 

 

 

 

e.

Date of the transaction

1. 19 May 2022 

2. 19 May 2022

f.

Place of the transaction

1. Outside of a trading venue 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company take responsibility for this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDUIGBDGDI
Date   Source Headline
27th Mar 20244:36 pmRNSGrant of Share Options
25th Mar 20247:00 amRNSFinal Results
27th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20243:31 pmRNSGrant of Share Options
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update and Notice of Results
10th Jan 202411:27 amRNSHolding(s) in Company
13th Dec 20232:19 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSTrading Update
6th Nov 202311:51 amRNSChange of Nominated Adviser and Broker
29th Sep 202310:36 amRNSDirector/PDMR Shareholding
25th Sep 202311:07 amRNSHolding(s) in Company
21st Sep 20234:42 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSHalf Yearly Report
29th Jun 20234:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
11th May 20234:44 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:20 pmRNSPDMR Transaction
28th Mar 20235:09 pmRNSGrant of share options
27th Mar 20237:00 amRNSFinal Results
24th Feb 202312:36 pmRNSExercise of Options and Total Voting Rights
9th Feb 20237:00 amRNSDirectorate Change
1st Feb 20237:00 amRNSTrading Update and Notice of Results
17th Nov 20223:29 pmRNSPDMR Transactions
16th Nov 20224:36 pmRNSDirector Dealing and Total Voting Rights
14th Nov 20223:54 pmRNSDirector/PDMR Shareholding
31st Oct 20223:45 pmRNSDirector Dealing and Total Voting Rights
4th Oct 20223:29 pmRNSExercise of Options and Total Voting Rights
4th Oct 20227:00 amRNSDirectorate Change
15th Sep 20227:00 amRNSHalf Yearly Report
23rd Aug 20224:27 pmRNSHolding(s) in Company
23rd Jun 20225:10 pmRNSResult of AGM
23rd Jun 20227:00 amRNSAGM Statement
1st Jun 20227:00 amRNSTotal Voting Rights
19th May 20227:00 amRNSDirectorate Change and Total Voting Rights
28th Apr 20222:08 pmRNSDirector Dealing and Total Voting Rights
27th Apr 20227:00 amRNSDirectorate Change
6th Apr 20225:24 pmRNSDirector Dealing and Total Voting Rights
28th Mar 20227:00 amRNSFinal Results
1st Mar 202210:09 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change, Director/PDMR Share Dealing
1st Feb 202211:33 amRNSTotal Voting Rights
31st Jan 20227:00 amRNSTrading Update and Notice of Results
24th Jan 20221:06 pmRNSDirector Dealing and Total Voting Rights
16th Dec 20211:31 pmRNSHolding(s) in Company
7th Dec 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSDirectorate Change
30th Sep 202110:13 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSHalf Yearly Report
31st Aug 20214:51 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.